Please Wait.....
Report
Middle East & Africa Immunodiagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Product [Enzyme-Linked Immunosorbent Assays (ELISA), Chemiluminescence Immunoassays (CLIA), Radioimmunoassays (RIA), and Others], Clinical Indication (Infectious Diseases, Hepatitis+HIV, Endocrinology, Gastrointestinal, Metabolics, and Others), and End User (Hospitals, Clinics, Diagnostic Laboratories, Academic & Research Institutes, and Others)
Market Report I 2023-01-19 I 198 Pages I The Insight Partners
The MEA immunodiagnostics market is expected to grow from US$ 591.94 million in 2022 to US$ 927.14 million by 2028; it is estimated to grow at a CAGR of 7.8% from 2022 to 2028.
Technological Advancements in Field of Immunodiagnostics is Fueling the MEA Immunodiagnostics Market
The current trend in immunodiagnostics is microfluidics and magnetic beads with potential commercialization. These sensitive, specific, and time-saving methodologies are essential in understanding and diagnosing various health conditions, including infectious diseases, metabolic disorders, and cardiac problems. The increasing applications of immunodiagnostic solutions encouraged the development of targeted treatments and therapies for precision health. The prominent market players are also propelling the assay technology and adopting microfluidics and magnetic beads. For immunoassays, magnetic particles such as Sera-Mag beads offer a convenient alternative to plate-based ELISAs, as both rely on the same assay principle. Merck KGaA launched the Magna Chip Protein A magnetic beads. This recombinant Protein A is covalently bound to magnetic beads for chromatin immunoprecipitations (Chip assays) and provides users with a rapid, reproducible, and efficient reagent for collecting immunocomplexes than agarose beads. In microfluidics, some immunodiagnostics target single biomarkers. However, a recent trend shows that a multiple analyte detection system is required according to the complexity of the disease and the need to make early reliable diagnoses. OPKO Health's test uses microfluidics, a recent development in immunodiagnostics, to assay an array of biomarkers. On September 15, 2022, Siemens Healthineers released its new CE-marked SARS-CoV-2/FluA/FluB/HRSV assay, a PCR test, and the CLINITEST Rapid COVID-19 + Influenza Antigen Test. The new FTD SARS-CoV-2/FluA/FluB/HRSV assay enables comprehensive and semi-automated molecular testing for seasonal respiratory pathogens. The combination PCR test detects and differentiates clinically relevant viruses such as SARS-CoV-2, Influenza A, Influenza B, and HRSV A/B.
MEA Overview
The MEA immunodiagnostics market is segmented into Saudi Arabia, the UAE, South Africa, and the Rest of MEA. Increasing usage of point-of-care diagnostics due to rising prevalence of chronic and infectious diseases such as liver and kidney diseases and emerging technologies across healthcare institutions are driving the immunodiagnostics market in the region. In Saudi Arabia, hypertension, diabetes, obesity, heart diseases, and asthma are reported as the common chronic diseases and are expected to be a major driving factor for the in-vitro diagnostics market in Saudi Arabia as immunoassay techniques are used in the diagnosis and monitoring of these diseases. For instance, according to the November 2021 report of the World Bank on the prevalence of noncommunicable diseases in Saudi Arabia, 185,500 new cases of cardiovascular disease; 303,500 new cases of chronic respiratory illness; and 2.1 million new cases of cancer were recorded. Further, as per the 2021 report of the International Diabetes Federation (IDF), the burden of diabetes in Saudi Arabia is expected to increase from 4.3 million in 2021 to 7.5 million by 2045. Further, the demand for immunoassay products is anticipated to upsurge in the country, which is expected to fuel the immunodiagnostics market in Saudi Arabia.
MEA Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
MEA Immunodiagnostics Market Segmentation
The MEA immunodiagnostics market is segmented into product, clinical indication, end user, and country.
Based on product, the MEA immunodiagnostics market is segmented into enzyme-linked immunosorbent assays (ELISA), chemiluminescence immunoassays (CLIA), radioimmunoassay (RIA), and others. The enzyme-linked immunosorbent assays (ELISA) segment registered the largest market share in 2022.
Based on clinical indication, the MEA immunodiagnostics market is segmented into infectious diseases, hepatitis+HIV, endocrinology, gastrointestinal, metabolics and others. The infectious diseases segment registered the largest market share in 2022.
Based on end user, the MEA immunodiagnostics market is segmented into hospitals, clinics, diagnostics laboratories, academic and research institutes, and others. The hospital segment registered the largest market share in 2022.
Based on country, the MEA immunodiagnostics market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of MEA. Saudi Arabia dominated the market in 2022.
Abbott Laboratories; bioMerieux SA; Danaher Corp; DiaSorin S.p.A.; F. Hoffmann-La Roche Ltd; PerkinElmer Inc.; Shenzhen Mindray Bio-Medical Electronics Co., Ltd.; Siemens Healthineers AG; Svar Life Science AB; and Thermo Fisher Scientific Inc are the leading companies operating in the MEA immunodiagnostics market.
TABLE OF CONTENTS
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 MEA Immunodiagnostics Market - By Product
1.3.2 MEA Immunodiagnostics Market - By Clinical Indication
1.3.3 MEA Immunodiagnostics Market - By End User
1.3.4 MEA Immunodiagnostics Market- By Country
2. MEA Immunodiagnostics Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. MEA Immunodiagnostics Market- Market Landscape
4.1 Overview
4.2 MEA PEST Analysis
4.3 Experts Opinion
5. MEA Immunodiagnostics Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Infectious Diseases
5.1.2 Growing Use of Point-of-Care Immunodiagnostics
5.2 Market Restraints
5.2.1 Inadequate Reimbursement Scenario
5.3 Market Opportunities
5.3.1 Rising Focus on R&D Investment and Expansion by Key Players
5.4 Future Trends
5.4.1 Technological Advancements in Immunodiagnostics
5.5 Impact Analysis
6. Immunodiagnostics Market- MEA Analysis
6.1 MEA Immunodiagnostics Market Revenue Forecast and Analysis
7. MEA Immunodiagnostics Market Analysis - by Product
7.1 Overview
7.2 MEA Immunodiagnostics Market, By Product, 2021 & 2028 (%)
7.3 Enzyme-linked immunosorbent assays (ELISA)
7.3.1 Overview
7.3.2 Enzyme-linked immunosorbent assays (ELISA): Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Chemiluminescence immunoassays (CLIA)
7.4.1 Overview
7.4.2 Chemiluminescence immunoassays (CLIA): Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.4.3 Vitamin D Assay
7.4.3.1 Overview
7.4.3.2 Vitamin D Assay: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.4.4 HIV Detection
7.4.4.1 Overview
7.4.4.2 HIV Detection: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.4.5 HIV Ag/Ab Combo assay
7.4.5.1 Overview
7.4.5.2 HIV Ag/Ab Combo assay: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.4.6 Other Tests
7.4.6.1 Overview
7.4.6.2 Other Tests: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.5 Radioimmunoassays (RIA)
7.5.1 Overview
7.5.2 Radioimmunoassays (RIA): Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
8. MEA Immunodiagnostics Market Analysis - Clinical Indication
8.1 Overview
8.2 MEA Immunodiagnostics Market Share by Clinical Indication - 2021 & 2028 (%)
8.3 Infectious Diseases:
8.3.1 Overview
8.3.2 Infectious Diseases: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.3 COVID-19
8.3.3.1 Overview
8.3.3.2 COVID-19: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.4 Tuberculosis
8.3.4.1 Overview
8.3.4.2 Tuberculosis: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.5 Lyme
8.3.5.1 Overview
8.3.5.2 Lyme: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.6 Infection Management
8.3.6.1 Overview
8.3.6.2 Infection Management: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.7 Zika
8.3.7.1 Overview
8.3.7.2 Zika: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.8 Treponema
8.3.8.1 Overview
8.3.8.2 Treponema: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.9 TORCH
8.3.9.1 Overview
8.3.9.2 TORCH: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.10 Measles and Mumps
8.3.10.1 Overview
8.3.10.2 Measles and Mumps: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.11 VZV
8.3.11.1 Overview
8.3.11.2 VZV: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.12 EBV
8.3.12.1 Overview
8.3.12.2 EBV: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.4 Hepatitis+HIV:
8.4.1 Overview
8.4.2 Hepatitis+HIV: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.5 Gastrointestinal
8.5.1 Overview
8.5.2 Gastrointestinal: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.6 Metabolics
8.6.1 Overview
8.6.2 Metabolics: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.7 Endocrinology
8.7.1 Overview
8.7.2 Endocrinology: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.7.3 Hypertension
8.7.3.1 Overview
8.7.3.2 Hypertension: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.7.4 Growth
8.7.4.1 Overview
8.7.4.2 Growth: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.7.5 Diabetes
8.7.5.1 Overview
8.7.5.2 Diabetes: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.7.6 Thyroid
8.7.6.1 Overview
8.7.6.2 Thyroid: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.7.7 Reproductive Endocrinology
8.7.7.1 Overview
8.7.7.2 Reproductive endocrinology: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
9. MEA Immunodiagnostics Market Analysis - End User
9.1 Overview
9.2 MEA Immunodiagnostics Market Share by End User - 2021 & 2028 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
9.4 Clinics
9.4.1 Overview
9.4.2 Clinics: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
9.5 Diagnostic Laboratories
9.5.1 Overview
9.5.2 Diagnostic Laboratories: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
9.6 Academic and Research Institutes
9.6.1 Overview
9.6.2 Academic and Research Institutes: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
9.7 Others
9.7.1 Overview
9.7.2 Others: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
10. MEA Immunodiagnostics Market Revenue and Forecast to 2028- by Country
10.1 Overview
10.1.2 Middle East & Africa: Immunodiagnostics Market, by Country, 2021 & 2028 (%)
10.1.2.1 Saudi Arabia: Immunodiagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.2.1.1 Saudi Arabia: Immunodiagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.2.1.2 Saudi Arabia Immunodiagnostics Market, by Product - Revenue and Forecast to 2028 (USD Million)
10.1.2.1.2.1 Saudi Arabia Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2028 (USD Million)
10.1.2.1.3 Saudi Arabia Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2028 (USD Million)
10.1.2.1.3.1 Saudi Arabia Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2028 (USD Million)
10.1.2.1.3.2 Saudi Arabia Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2028 (USD Million)
10.1.2.1.4 Saudi Arabia: Immunodiagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
10.1.2.2 South Africa: Immunodiagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.2.2.1 South Africa: Immunodiagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.2.2.2 South Africa Immunodiagnostics Market, by Product - Revenue and Forecast to 2028 (USD Million)
10.1.2.2.2.1 South Africa Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) - Revenue and Forecast to 2028 (USD Million)
10.1.2.2.3 South Africa Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2028 (USD Million)
10.1.2.2.3.1 South Africa Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2028 (USD Million)
10.1.2.2.3.2 South Africa Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2028 (USD Million)
10.1.2.2.4 South Africa Immunodiagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
10.1.2.3 UAE: Immunodiagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.2.3.1 UAE: Immunodiagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.2.3.2 UAE Immunodiagnostics Market, by Product - Revenue and Forecast to 2028 (USD Million)
10.1.2.3.2.1 UAE Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) - Revenue and Forecast to 2028 (USD Million)
10.1.2.3.3 UAE Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2028 (USD Million)
10.1.2.3.3.1 UAE Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2028 (USD Million)
10.1.2.3.3.2 UAE Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2028 (USD Million)
10.1.2.3.4 UAE Immunodiagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
10.1.2.4 Rest of Middle East & Africa: Immunodiagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.2.4.1 Rest of Middle East & Africa: Immunodiagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.2.4.2 Rest of Middle East & Africa Immunodiagnostics Market, by Product - Revenue and Forecast to 2028 (USD Million)
10.1.2.4.2.1 Rest of Middle East & Africa Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) - Revenue and Forecast to 2028 (USD Million)
10.1.2.4.3 Rest of Middle East & Africa Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2028 (USD Million)
10.1.2.4.3.1 Rest of Middle East & Africa Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2028 (USD Million)
10.1.2.4.3.2 Rest of Middle East & Africa Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2028 (USD Million)
10.1.2.4.4 Rest of Middle East & Africa Immunodiagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
11. Global Immunodiagnostics Market -Industry Landscape
11.1 Overview
11.2 Inorganic Growth Strategies
11.2.1 Overview
11.3 Organic Growth Strategies
11.3.1 Overview
12. Company Profiles
12.1 Abbott Laboratories
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 F. Hoffmann-La Roche Ltd
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 DiaSorin S.p.A.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Danaher Corp
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Thermo Fisher Scientific Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 PerkinElmer Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 bioMerieux SA
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Svar Life Science AB
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Siemens Healthineers AG
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. MEA Immunodiagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Table 2. Saudi Arabia Immunodiagnostics Market, by Product - Revenue and Forecast to 2028 (USD Million)
Table 3. Saudi Arabia Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2028 (USD Million)
Table 4. Saudi Arabia Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2028 (USD Million)
Table 5. Saudi Arabia Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2028 (USD Million)
Table 6. Saudi Arabia Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2028 (USD Million)
Table 7. Saudi Arabia Immunodiagnostics Market, by End User- Revenue and Forecast to 2028 (USD Million)
Table 8. South Africa Immunodiagnostics Market, by Product -Revenue and Forecast to 2028 (USD Million)
Table 9. South Africa Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) -Revenue and Forecast to 2028 (USD Million)
Table 10. South Africa Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2028 (USD Million)
Table 11. South Africa Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2028 (USD Million)
Table 12. South Africa Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2028 (USD Million)
Table 13. South Africa Immunodiagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 14. UAE Immunodiagnostics Market, by Product -Revenue and Forecast to 2028 (USD Million)
Table 15. UAE Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) -Revenue and Forecast to 2028 (USD Million)
Table 16. UAE Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2028 (USD Million)
Table 17. UAE Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2028 (USD Million)
Table 18. UAE Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2028 (USD Million)
Table 19. UAE Immunodiagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 20. Rest of Middle East & Africa Immunodiagnostics Market, by Product -Revenue and Forecast to 2028 (USD Million)
Table 21. Rest of Middle East & Africa Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) -Revenue and Forecast to 2028 (USD Million)
Table 22. Rest of Middle East & Africa Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2028 (USD Million)
Table 23. Rest of Middle East & Africa Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2028 (USD Million)
Table 24. Rest of Middle East & Africa Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2028 (USD Million)
Table 25. Rest of Middle East & Africa Immunodiagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 26. Recent Inorganic Growth Strategies in the Immunodiagnostics Market
Table 27. Recent Organic Growth Strategies in the Immunodiagnostics Market
Table 28. Glossary of Terms, MEA Immunodiagnostics Market
LIST OF FIGURES
Figure 1. MEA Immunodiagnostics Market Segmentation
Figure 2. MEA Immunodiagnostics Market Segmentation, By Country
Figure 3. MEA Immunodiagnostics Market Overview
Figure 4. MEA Immunodiagnostics Market, by Product
Figure 5. MEA Immunodiagnostics Market, by Country
Figure 6. Middle East & Africa PEST Analysis
Figure 7. MEA Immunodiagnostics Market: Impact Analysis of Drivers and Restraints
Figure 8. MEA Immunodiagnostics Market- Revenue Forecast and Analysis - 2020 - 2028
Figure 9. MEA Immunodiagnostics Market, by Product, 2021 & 2028 (%)
Figure 10. Enzyme-linked immunosorbent assays (ELISA): MEA Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 11. Chemiluminescence immunoassays (CLIA): MEA Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 12. Vitamin D Assay: MEA Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 13. HIV Detection: MEA Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 14. HIV Ag/Ab Combo assay: MEA Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 15. Other Tests: MEA Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 16. Radioimmunoassays (RIA): MEA Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 17. Others: MEA Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 18. MEA Immunodiagnostics Market Share by Clinical Indication - 2021 & 2028 (%)
Figure 19. Infectious Diseases: MEA Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 20. COVID-19: MEA Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 21. Tuberculosis: MEA Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 22. Lyme: MEA Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 23. Infection Management: MEA Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 24. Zika: MEA Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 25. Treponema: MEA Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 26. TORCH: MEA Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 27. Measles and Mumps: MEA Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 28. VZV: MEA Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 29. EBV: MEA Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 30. Hepatitis+HIV: MEA Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 31. Gastrointestinal: MEA Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 32. Metabolics: MEA Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 33. Endocrinology: MEA Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 34. Hypertension: MEA Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 35. Growth: MEA Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 36. Diabetes: MEA Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 37. Thyroid: MEA Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 38. Reproductive endocrinology: MEA Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 39. Others: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 40. MEA Immunodiagnostics Market Share by End User - 2021 & 2028 (%)
Figure 41. Hospitals: MEA Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 42. Clinics: MEA Immunodiagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 43. Diagnostic Laboratories: MEA Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 44. Academic and Research Institutes: MEA Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 45. Others: MEA Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 46. Middle East & Africa: Immunodiagnostics Market, by Key Country - Revenue (2021) (USD Million)
Figure 47. Middle East & Africa: Immunodiagnostics Market, by Country, 2021 & 2028 (%)
Figure 48. Saudi Arabia: Immunodiagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 49. South Africa: Immunodiagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 50. UAE: Immunodiagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 51. Rest of Middle East & Africa: Immunodiagnostics Market - Revenue and Forecast to 2028 (USD Million)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security